This strategy has wide applicability for delivering therapeutic agents (including viruses, therapeutic nucleic acids, drugs) to tumor cells and when combined with the ability to produce and secrete a therapeutic cytokine (such as mda-7/IL-24 in the CTV) engenders this approach with the ability to treat both primary and metastatic tumors. Here, IL24 is linked to neoplasm.